Laserfiche WebLink
of concern at the site are judged unlikely to result in adverse noncarcinogenic health <br /> effects. If the sum is greater than 1.0, a more detailed and critical evaluation of <br /> potential noncarcinogenic health hazards may be warranted. Such additional evaluation <br /> may include the consideration of the specific target organ(s) affected and mechanism(s) <br /> of action of the chemicals of concern, and consideration of exposure assumptions and <br /> exposure concentrations used to estimate risk. <br /> The assumption of additive effects reflected in the cumulative H.I. is most properly <br /> applied to substances that induce the same effect by the same mechanism (EPA 1989b). <br /> Consequently, application of the equation to a mixture of substances that are not <br /> expected to induce the same type of effects could overestimate the potential for adverse -� <br /> health effects. The H.I. provides a rough measure of potential toxicity, but it is <br /> conservative and dependent on the quality of the experimental evidence. Since the H.I. -- <br /> does not define dose-response relationships, its numerical value cannot be construed as <br /> a direct estimate of risk (EPA 1989b), but only as a level of concern. <br /> 6.2.2 Carcinogenic Risk <br /> Carcinogenic risk is defined as the upperbound incremental probability of an individual <br /> developing cancer over a lifetime as a result of exposure to a potential carcinogen. The <br /> numerical estimate of excess lifetime cancer risk is calculated by multiplying the <br /> chemical intake averaged over a lifetime by the cancer slope factor (SF) as follows: <br /> Risk = Chemical Intake (mg/kg-day) x SF (mg/kg-day)"'The EPA slope factors are upper 95th percentile confidence limits of the probability of <br /> response per unit uptake of chemical over a lifetime. Slope factors are based on <br /> experimental animal data and epidemiological studies when available. A linear <br /> nonthreshold mathematical model for low-dose extrapolation, the linearized multistage <br /> model, is used to calculate numerical slope factor value. EPA states that carcinogenic <br /> risks estimated using this approach are upper-bound estimates. This means that the <br /> actual risk is likely to be less than the predicted risk (EPA 1989b). <br /> S:\LDC\YELLO.RPT May 4,1995 6-3 <br />